pricing

Views & Analysis

On the pulse of ASCO: pricing and clinical trial access

New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.

News

Gilead faces lawsuit over HIV drug pricing

Gilead and other pharma companies stand accused of engaging in a scheme to block cheaper competitors to life-saving HIV drugs from entering the market.

Views & Analysis

VPAS 2024: What should industry consider next time?

The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded medicines spend; the 2019 Voluntary Scheme for Branded Medicines Pricing

News

Teva vows to fight price-fixing lawsuit

Teva has said it will defend itself against a lawsuit raised by 44 US states that alleges the company was the ringleader in an illegal price-fixing scheme involving 19 other generic compani

Partner Content

$Banner for Media partners {460x250px}_5th Pre-Filled$

Partner Content

5th Annual Pre-Filled Syringes & Injectables Summit

Welcome to the 5th anniversary edition of the Pre-Filled Syringes & Injectables Summit on September 18-19, 2019, in Düsseldorf, Germany.

News

NICE backs funding for MSD's diabetes drug Steglatro

NICE has recommended that England’s NHS should routinely fund Merck, Sharpe, and Dohme’s type 2 diabetes drug Steglatro in a final decision, after the company undercut rivals from the same

On the pulse of ASCO: pricing and clinical trial access

Gilead faces lawsuit over HIV drug pricing

VPAS 2024: What should industry consider next time?

Teva vows to fight price-fixing lawsuit

5th Annual Pre-Filled Syringes & Injectables Summit

NICE backs funding for MSD's diabetes drug Steglatro

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

pricing

Editor's Picks